Novavax | NVAX - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Adma Biologics USD 50.4M 8.24M 2025-12
Agenus USD 642K 399K 2025-09
AstraZeneca USD -204M 3.48B 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Cassava Sciences USD 3.96M 1.16M 2025-09
Geron USD 1.31M 263K 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
MannKind USD 33.65M 13.44M 2025-12
Merck USD 2.94B 380M 2026-03
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 955M 503M 2026-03
Novartis USD 3.54B 7M 2025-12
Novavax USD 22.1M 608K 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
TG Therapeutics USD 38.14M 10.05M 2025-12